Pancreatic neuroendocrine tumors (pNETs) are a heterogeneous group of tumors with
complicated treatment options that depend on pathological grading, clinical staging, and …

Pancreatic neuroendocrine tumors (PNETs) are known to be the second most common
epithelial malignancy of the pancreas. PNETs can be listed among the slowest growing as …

Nonfunctional neuroendocrine tumors of the pancreas (NF-PNETs) are a heterogeneous
group of neoplasms. Although rare, the incidence of NF-PNETs is increasing significantly …

Pancreatic neuroendocrine tumours (PET) are rare neoplasms of the pancreas accounting
for less than 5% of all primary pancreatic malignancies. Included in this group are …

Pancreatic neuroendocrine tumors (pNETs) constitute a heterogenous group of
malignancies with varying clinical presentation, tumor biology and prognosis. The incidence …

Pancreatic neuroendocrine tumors (pNETs) are rare heterogeneous tumors that have been
steadily increasing in both incidence and prevalence during the past few decades …

Pancreatic neuroendocrine tumors (NET) have diverse clinical presentations. Patients with
symptoms of hormone secretion may require specific medical interventions to control those …

Abstract Background Neuroendocrine tumors (NETs) are rare neoplasms, with an estimated
annual incidence of~ 6.9/100,000. NETs arise throughout the body from cells of the diffuse …

Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are a heterogeneous group of
neoplasms arising from the diffuse neuroendocrine system. The incidence of GEP-NETs has …

Pancreatic neuroendocrine tumors (PNETs) are relatively rare; however, the incidence has
increased over the last few decades. They are classified as functional or non-functional …